Charter to Participate in Goldman Sachs Communacopia Conference
Get Alerts CHTR Hot Sheet
Join SI Premium – FREE
STAMFORD, Conn., Sept. 17, 2019 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR) today announced that Tom Rutledge, Chairman and Chief Executive Officer, will participate in the Goldman Sachs Communacopia Conference in New York, NY today, September 17, 2019. Mr. Rutledge's remarks are scheduled to begin at 2:05 p.m. ET.

A live webcast of the event can be accessed on Charter's investor relations website, ir.charter.com. Following the live broadcast, the webcast will be archived at ir.charter.com.
About Charter Charter Communications, Inc. (NASDAQ: CHTR) is a leading broadband communications company and the second largest cable operator in the United States. Charter provides a full range of advanced residential broadband services, including Spectrum TV® programming, Spectrum Internet®, Spectrum Voice®, and Spectrum Mobile™. Under the Spectrum Business® brand, Charter provides scalable, and cost-effective broadband communications solutions to small and medium-sized business organizations, including Internet access, business telephone, and TV services. Through the Spectrum Enterprise brand, Charter is a national provider of scalable, fiber-based technology solutions serving many of America's largest businesses and communications service providers. Charter's advertising sales and production services are sold under the Spectrum Reach® brand. Charter's news and sports networks are operated under the Spectrum Networks brand. More information about Charter can be found at newsroom.charter.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/charter-to-participate-in-goldman-sachs-communacopia-conference-300919194.html
SOURCE Charter Communications, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- More than 160,000 Duke Energy customers in Ohio and Kentucky remain without power as second round of storms is expected
- New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
- OPENLANE Announces Pricing of Secondary Offering of Common Stock, Including Concurrent Share Repurchase
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share